KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$80.79
Tradestie Score
48
Market Cap
$2.86B
P/E Ratio
83.9
Revenue Growth
0.6%
Analyst Upside
+21.3%

Top Competitors

45 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$9.81
$7.83B - 28 Compare
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$90.90
$6.64B - 70 Compare
KRYS Krystal Biotech, Inc. Common Stock
$320.13
$5.20B 40.1 64 Compare
ALKS Alkermes Inc. plc
$44.18
$5.06B 117.5 43 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$83.10
$3.67B - 68 Compare
LNTH Lantheus Holdings, Inc
$100.10
$3.51B 24.3 48 Compare
SRRK Scholar Rock Holding Corporation Common Stock
$41.96
$3.33B - 71 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$20.48
$3.26B 40.4 51 Compare
PBH Prestige Consumer Healthcare Inc.
$49.46
$3.12B 13.4 51 Compare
PRGO PERRIGO COMPANY PLC
$16.37
$3.10B - 29 Compare

Data updated: Oct 23, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

45 stocks in this industry